4//SEC Filing
Pierce Robert Hamilton 4
Accession 0001209191-21-050659
CIK 0001829802other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 5:40 PM ET
Size
9.4 KB
Accession
0001209191-21-050659
Insider Transaction Report
Form 4
Pierce Robert Hamilton
Chief Scientific Officer
Transactions
- Sale
Common Stock
2021-08-09$7.06/sh−6,982$49,295→ 82,380 total(indirect: By Spouse) - Sale
Common Stock
2021-08-10$7.13/sh−66,350$473,003→ 16,030 total(indirect: By Spouse) - Sale
Common Stock
2021-08-06$7.11/sh−6,460$45,948→ 89,362 total(indirect: By Spouse)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.04 to $7.20, inclusive. The reporting person undertakes to provide to Sensei Biotherapeutics, Inc., any security holder of Sensei Biotherapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3) and (4) to this Form 4.
- [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.10, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.42, inclusive.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
Related Parties
1- filerCIK 0001594129
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 5:40 PM ET
- Size
- 9.4 KB